768: Phase II study of a multi-targeted antifolate (LY231514) (MTA) as first line therapy in patients with locally advanced or metastatic colorectal cancer (MCC)
- 30 September 1997
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S172
- https://doi.org/10.1016/s0959-8049(97)85402-0
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: